DEFINITIVE PROXY STATEMENT

Company

Anika Therapeutics, Inc.

Filed

December 6, 1996

Period of Report

January 8, 1997

Accession Number

0000950109-96-008144

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →